Thomas W. Dubensky - 03 Jan 2023 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
President, Director
Signature
/s/ Stephen Brady, Attorney-in-Fact for Thomas W. Dubensky
Issuer symbol
TPST
Transactions as of
03 Jan 2023
Net transactions value
$0
Form type
4
Filing time
05 Jan 2023, 19:01:41 UTC
Previous filing
19 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Employee Stock Option (right to buy) Award $0 +102,700 $0.000000 102,700 03 Jan 2023 Common Stock 102,700 $1.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest in a series of 48 equal monthly installments measured from January 3, 2023, subject to the reporting person's continued service.